Organ distribution of transgene expression following intranasal mucosal delivery of recombinant replication-defective adenovirus gene transfer vector

Genetic Vaccines and Therapy

Volumn 6, Issue , 2008, Pages

  Damjanovic, Daniela ^a   Zhang, Xizhong ^a   Mu, Jingyu ^a   Fe Medina, Maria ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; LUCIFERASE; RECOMBINANT VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GENE EXPRESSION; GENE SEQUENCE; GENE TRANSFER; IMMUNIZATION; LUNG; LYMPH NODE; MOUSE; NONHUMAN; OLFACTORY BULB; ORGAN DISTRIBUTION; POLYMERASE CHAIN REACTION; RESPIRATORY SYSTEM; RESPIRATORY TRACT MUCOSA; SPLEEN; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE;

EID: 40349087263     PISSN: None     EISSN: 14790556     Source Type: Journal    
DOI: 10.1186/1479-0556-6-5     Document Type: Article

References (20)

1. Ambrose CS Walker RE Connor EM: Live attenuated influenza vaccine in children. Semin Pediatr Infect Dis 2006, 17:206-12. 10.1053/ j.spid.2006.08.007 17055372
2. Belshe R Lee MS Walker RE Stoddard J Mendelman PM: Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine. Expert Rev Vaccines 2004, 3:643-54. 10.1586/14760584.3.6.643 15606348
3. Van Kampen KR Shi Z Gao P Zhang J Foster KW Chen DT Marks D Elmets CA Tang DC; Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 2005, 23:1029-36. 10.1016/j.vaccine.2004.07.043 15620476
4. Wang J Thorson L Stokes RW Santosuosso M Huygen K Zganiacz A Hitt M Xing Z: Single Mucosal, but not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis. J Immunol 2004, 173:6357-6365. 15528375
5. Santosuosso M McCormick S Zhang X Zganiacz A Xing Z: Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral BCG immunization against pulmonary tuberculosis. Infect Immun 2006, 74:4634-43. 1539608 16861651 10.1128/IAI.00517-06
6. Xing Z Lichty BD: Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization. Tuberculosis (Edinb) 2006, 86:211-7. 10.1016/j.tube.2006.01.017 16504584
7. Goonetilleke NP McShane H Hannan CM Anderson RJ Brookes RH Hill AVS; Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of Bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara. J Immunol 2003, 171:1602-9. 12874255
8. Dietrich J Andersen C Rappuoli R Doherty M Jensen CG Andersen P: Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity. J Immunol 2006, 177:6353-60. 17056566
9. Illum L: Nasal drug delivery - possibilities, problems and solutions. J Control Release 2003, 87:187-198. 10.1016/S0168-3659(02)00363-2 12618035
10. Lemiale F Kong W Akyürek LM Ling X Huang Y Chakrabarti BK Eckhaus M Nabel GJ: Enhanced Mucosal Immunoglobulin A Response of Intranasal Adenoviral Vector Human Immunodeficiency Virus Vaccine and Localization in the Central Nervous System. J Virol 2003, 77:10078-10087. 224584 12941918 10.1128/JVI.77.18.10078-10087.2003
11. Doi K Nibu K Ishida H Okado H Terashima T; Adenovirus-mediated gene transfer in olfactory epithelium and olfactory bulb: A long-term study. Ann Otol Rhinol Laryngol 2005, 114:629-33. 16190096
12. Arimoto Y Nagata H Isegawa N Kumahara K Isoyama K Konno A Shirasawa H; In vivo expression of adenovirus-mediated lacZ gene in murine nasal mucosa. Acta Otolaryngol 2002, 122:627-33. 10.1080/000164802320396303 12403125
13. Xing Z Santosuosso M McCormick S Yang T-C Millar J Hitt M Wan Y Bramson J Vordermeier HM: Recent advances in the development of adenovirus- and poxvirus-vectored tuberculosis vaccines. Curr Gene Ther 2005, 5:485-492. 10.2174/156652305774329230 16250889
14. Sallenave J-M Xing Z Simpson AJ Graham FL Gauldie J: Adenovirus-mediated expression of an elastase-specific inhibitor (elafin): A comparison of different promoters. Gene Ther 1998, 5:352-360. 10.1038/sj.gt.3300610 9614555
15. Xing Z Stampfli MR Gauldie J; Transient transgenic approaches for investigating the role of granulocyte-macrophage colony-stimulating factor in pulmonary inflammatory and immune diseases. Methods Mol Med 2000, 4:161-178.
16. Hutchins Beth Making the (clinical) grade with adenoviral gene therapy vectors. Qual Assur J 1997, 2:119-127. 10.1002/ (SICI)1099-1786(199709)2:3<119::AID-QAJ44>3.0.CO;2-T
17. Xing Z Ohkawara Y Jordana M Graham FL Gauldie J: Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J Clin Invest 1996, 97:1102-1110. 507158 8613534
18. Lei XF Ohkawara Y Stämpfli MR Gauldie J Croitoru K Jordana M Xing Z: Compartmentalized transgene expression of granulocyte-macrophage colony-stimulating factor (GM-CSF) in mouse lung enhances allergic airways inflammation. Clin Exp Immunol 1998, 113:157-165. 1905049 9717963 10.1046/j.1365-2249.1998.00652.x
19. Källenius G Pawlowski A Brandtzaeg P Svenson S: Should a new tuberculosis vaccine be administered intranasally? Tuberculosis (Edinb) 2007 Feb 23;
20. Johnson M Huyn S Burton J Sato M Wu L: Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction. Hum Gene Ther 2006, 17:1262-1269. 10.1089/hum.2006.17.1262 17117891